An inducible, isogenic cancer cell line system for targeting the state of mismatch repair deficiency. | PLoS One;8(10): e78726, 2013. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

An inducible, isogenic cancer cell line system for targeting the state of mismatch repair deficiency.

Bailis, Julie M; Gordon, Marcia L; Gurgel, Jesse L; Komor, Alexis C; Barton, Jacqueline K; Kirsch, Ilan R.

Affiliation

Bailis JM; Oncology Research, Amgen Inc., South San Francisco, California, United States of America.

PLoS One ; 8(10): e78726, 2013.

Article in En | MEDLINE | ID: mdl-24205301

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cell Line, Tumor / DNA Mismatch Repair Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2013 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cell Line, Tumor / DNA Mismatch Repair Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2013 Document type: Article Affiliation country: